HIV mutation literature information.


  Relatively high prevalence of drug resistance among antiretroviral-naive patients from Henan, Central China.
 PMID: 23800338       2014       AIDS research and human retroviruses
Abstract: The unexpectedly high percentage of drug resistance in Henan province is mainly due to the prevalence of minor mutations in the protease and integrase regions, especially A71T/V and L68V/I/IM/LV.


  Characteristics of HIV-1 natural drug resistance-associated mutations in former paid blood donors in Henan Province, China.
 PMID: 24586665       2014       PloS one
Discussion: Results from the HIV-1 drug resistance mutation research by the International AIDS Society-USA (updated in March 2013) have revealed that PI resistance mutation sites are L10I, K20M, V32I, M36I, M46I/L, I47V/A, I50V, Q58E, A71V, G73S, V82A/F/T, I84V, L89V,L90M; NRTIs resistance mutations are M41L, A62V,  PMID: 24629078       2014       BMC bioinformatics
Result: According to the IAS-USA, the mutations associated with drug resistance, with a p >10%, were L10I, M36I, I62V, L63P, I64V, A71V/T, V77I, L90M, and I93L.


  The prevalence of transmitted HIV drug resistance among MSM in Anhui province, China.
 PMID: 25035709       2014       AIDS research and therapy
Result: However, some accessory mutations that did not affect susceptibility to ARV drugs were found in the protease gene, including L10I/L/V (3.0%; 4/133), V11I/V (3.0%; 4/133), L33F (2.3%; 3/133), and A71A/V/T (12.8%; 17/133).
Discussion: Other commonly observed mutations were T69A/N/S, V179E, L10I/L/V, V11I/V, L33F, and A71A/T/V; none of these mutations is known to confer drug resistance to NRTIs, NNRTIs, or PIs.
Discussion: The prese


  Systematic molecular dynamics, MM-PBSA, and ab initio approaches to the saquinavir resistance mechanism in HIV-1 PR due to 11 double and multiple mutations.
 PMID: 25036111       2014       The journal of physical chemistry. B
Abstract: Herein, we extend our analysis, which includes seven double (G48V-V82A, L10I-G48V, G48V-L90M, I84V-L90M, L10I-V82A, L10I-L63P, A71V-G73S) and four multiple (L10I-L63P-A71V, L10I-G48V-V82A, G73S-I84V-L90M,


  Structural basis and distal effects of Gag substrate coevolution in drug resistance to HIV-1 protease.
 PMID: 25355911       2014       Proc Natl Acad Sci U S A
Abstract: To understand the molecular basis of this protease-substrate coevolution, we solved the crystal structures of drug resistant I50V/A71V HIV-1 protease with p1-p6 substrates bearing coevolved mutations.


  HIV-1 Antiretroviral Drug Resistance in Pregnant Women in Jamaica: A Preliminary Report.
 PMID: 25803373       2014       The West Indian medical journal
Abstract: Three minor protease resistant-conferring mutations (A71AT, A71V, A71T) and five mutations conferring high to low-level resistance (K219EK, T69S, K103S, G190A and K103N) were detected in the RT region.


  Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity.
 PMID: 25575025       2014       Retrovirology
Table: A71V


  HIV-1 transmitted drug resistance-associated mutations and mutation co-variation in HIV-1 treatment-naive MSM from 2011 to 2013 in Beijing, China.
 PMID: 25510523       2014       BMC infectious diseases
Abstract: Fifty-seven sa
Result: PI mutations included L10I/V (7.2%, 16/223) and A71L/T/V (6.3%, 14/223), with relatively high frequency; NRTI mutations, included L74I (0.45%, 1/223) and V75L (0.45%, 1/223); and the most frequent NNRTI mutation was V179D/E (5.4%, 12/223).
Result: Among CRF07_BC recombinant strains, 21.0% (13/62) had TDR-associated mutations, A71T/V being the most frequent.


  HIV-1 diversity, transmission dynamics and primary drug resistance in Angola.
 PMID: 25479241       2014       PloS one
Result: A71T was found in one patient infected with a subtype C virus and A71V was found in two patients infect with subtype D.
Result: A71T/V are polymorphisms that occur in 2-3% of untreated individuals but the frequency increases in patients receiving PIs.



Browser Board

 Co-occurred Entities




   Filtrator